Language Selector

    Partner Offer for Health Topic SC1-BHC-11-2020

    Published on 05 March 2020
    Author: Nicole Wyss, National Contact Point Health

    A Swiss SME is looking to join a consortium for the open topic SC1-BHC-11-2020: Advancing the safety assessment of chemicals without the use of animal testing.

    Nagi Bioscience, a Swiss SME based in Lausanne is looking for a consortium.

    The company developed the first all-in-one device for fully automated high-content screening on a whole-organism: the microscopic worm C. elegans, great scientific and ethical alternative to traditional animal testing.The technology can be used to develop and execute a new class of bioassays for various applications in the field of predictive toxicology and drug discovery/development.

    The deadline for the proposal is 7 April 2020.

    In case you are interested please contact Mr Matteo Cornaglia.

    More information